Description

SNOG SYMPOSIUM 2024

Multidisciplinary Neuro-Oncology Meeting

25^th – 27^thApril

Gothenburg
Sweden

Welcome to,

Scandinavian Society of Neuro-oncology (SNOG) symposium, which will be held at Clarion Hotel Draken, Olof Palmes Plats 2, Gothenburg, Sweden 25^th – 27^th April, 2024.

The symposium is targeted to clinical experts, clinical researchers, basic scientists and students who work with improving lives for patients with brain tumors.

Scandinavian Society of Neuro-oncology (SNOG) was established in 1980s with the overall aim to increase communication between Scandinavian neuro-oncology experts, including both basic scientists and clinicians. One important aim of SNOG is to facilitate new collaborations and improve those already established. The SNOG meeting is an excellent arena to exchange ideas, and this is the key event organized by the society.

Language: English
Number of Participants: 170
Form of Symposium: Lectures and discussion
Registration Fee: 4.600 SKR
Application deadline: March 25, 2024 – Note! Limited number of places, first came – first served!

What is included in the registration fee?
Admission to all scientific sessions
Admission to exhibition
Final Program
Coffee/tea during breaks
Lunch April 25, April 26, April 27
Dinner April 26

Link to meeting registration:
https://cancerakademin.se/evenemang/snog-symposium-2024-multidisciplinary-neuro-oncology-meeting/

About hotel reservation
We highly recommend you to reserve a room at Clarion Hotel Draken, where the symposium is also held. They have reserved rooms for the participants with a special price.

More information about the hotel by this link https://www.strawberry.se/hotell/sverige/goteborg/clarion-hotel-draken/

You can reserve your hotel room by clicking the link below:
Clarion Hotel Draken 25-27 april 2024

Special prices for participants:
Room for one person (single room) 155 EUR per night
Room for two persons (double room) 175 EUR per night
All prices are per room and per night, including breakfast buffet, Wi-Fi and VAT.

These prices are valid until February 23, 2024.

NOTE! Hotel rooms are not included in the congress fee. The hotel rooms have to be booked and paid by each participant.

ABSTRACT
The Scandinavian Neuro-oncology Group (SNOG) encourages the submission of abstracts concerning all categories of research involving tumors involving the central nervous system (clinical, pre-clinical, translational, qualitative, register-based, etc.) but also descriptions of completed or ongoing development or quality assurance projects within the field.

Submit your abstract to SNOG by e-mail to: monica.sandstrom@umu.se

The abstract submission deadline is Monday March 4, 2024.

Instructions

Language
Abstracts can be submitted in English.

Word limit
The character limit set for all abstract categories is 2 000 characters (excluding spaces). The character limit does not include the author names and affiliations or the references.

Structure
The abstract should include the following:

A title that reflect the content of the abstract
Names and affiliations of all authors, with the name of the presenting author either underlined or in bold
E-mail address of the presenting author
An introductory brief background indicating the rationale of the study
A brief description of methodological procedures
A summary of the results
A statement of the main conclusions
A brief reflection on clinical significance and future perspectives
References (if applicable)
Funding (if applicable)
Disclosures (if applicable)

Let us know if you primarily want:

Oral
Poster
No preference

Poster presentation
Instructions for the making of posters will be sent to the presenting author in connection with a notification that the abstract has been accepted. During the meeting, a prize will be awarded to the presenter of the best poster!

We hope that this will be an interesting and productive meeting and look forward to see you in Gothenburg in April 2024.

Welcome!

Asgeir Jakola
Professor
President SNOG
on behalf of
SNOG Organizing committee

Members of the organising & scientific committee

Asgeir Jakola, Gothenburg, Sweden
Bjarne Winther Kristensen, København, Denmark
Anja Smits, Gothenburg, Sweden
Maria Sandström, Umeå, Sweden
Jiri Bartek, Stockholm, Sweden
Roger Henriksson, Umeå, Sweden
Magnus Olivecrona, Örebro, Sweden
Helena Carén, Gothenburg, Sweden
Annelli Ozanne, Gothenburg, Sweden
Kirsi Rautajoki, Tampere, Finland.
Ole Solheim, Trondheim, Norway

Skriv ut

April 25
12.00 - 12.10	Welcome	Asgeir Jakola, Gothenburg/Sweden
	Cognition - Chair - Anneli Ozanne
12.10 - 12.40	Cognitive rehabilitation - lessons learned	Karin Gehring, Tillburg/The Netherlands
12.40 - 12.47	Abstract
12.50 - 13.05	Cognitive trajectories in IDH mut glioma	Isabelle Rydén, Gothenburg/Sweden
	Brain tumor diagnosis; beyond clinical routine - Chair - Bjarne W. Kristensen
13.10 - 13.40	Liquid biopsies	Susan Short, Leeds/UK
13.40 - 14.00	Brain Cancer: From Biology to Early Detection	Petra Hamerlik, Manchester/UK
14.00 - 14.15	DNA methylation diagnostics of brain tumors now and in the future	Kirsi Rautajoki, Finland
14.15 - 14.30	PET in diagnosis of brain tumors	Ian Law, Copenhagen/DK
14.30 - 14.37	Abstract
14.40 - 14.55	Metabolic patterns before glioma diagnosis	Sebastian Löding, Umeå/Sweden
14.55 - 15.15	Coffee/Exhibition
	Radiotherapy - Chair - Maria Sandström
15.15 - 15.30	Novel PET tracers in mangement of brain metastasis	Pirjo Laakkonen, Helsinki/Finland
15.30 - 15.45	Swedish proton experience in LGG / PRO GLIO UPDATE	Malin Blomstrand, Gothenburg/Sweden
15.45 - 15.52	Abstract
15.55 - 16.25	Experience of intraoperative radiotherapy	Klaus Henning Kahl, Augsburg/Germany
	Tumor microenvironment - Chair - Kirsi Rautajoki
16.30 - 17.00	Tumor-host interdependance	Vidhya Madapusi Ravi, Freiburg/Germany
17.00 - 17.15	Tertiary lymphoid structures; relevance in brain tumors?	Anna Dimberg, Uppsala/Sweden
17.15 - 17.30	Tumor surfaceome - the key to effective immunotherapy?	Mattias Belting, Lund/Sweden
17.30 - 17.45	Influence of the microenvironment on chemosensitivity in glioblastoma	Rikke Frydendahl Sick Olsen, Odense/Denmark
17.45 - 18.00	Coffee/Exhibition
	Quality of life - Chair - Anja Smits
18.00 - 18.15	Reproductive health and sexuality	Claudia Lampic, Umeå/Sweden
18.15 - 18.30	Feasibility of shared decision making in neuro-oncology	Helle Sørensen Von Essen, Odense/Denmark
18.30 - 18.45	Functional consequences of SMA and M1 resections	Mattias Stålnacke, Umeå/Sweden
18.45 - 19.00	Support to patients with glioblastoma and their proxies	Pernilla Ståhl, Gothenburg/Sweden

April 26
	Meningiomas - Chair - Anneli Ozanne
08.30 - 08.45	Epidemiology and Incidental meningiomas	Olivia Näslund, Gothenburg/Sweden
08.45 - 09.15	Molecular classification of meningiomas	Felix Sahm, Heidelberg/Germany
09.15 - 09.30	Radiotherapy as primary option for meningiomas	Bente Sandvei Skeie, Bergen/Norway
09.30 - 09.45	Copenhagen meningioma score	Tiit Mathiesen, Copenhagen/Denmark
09.45 - 09.52	Abstract
09.52 - 09.59	Abstract
10.00 - 10.07	Abstract
10.07 - 10.14	Abstract
10.15 - 10.45	Meningiomas, new horizons	Thomas Graillon, Marseille/France
11.00 - 12.00	Poster viewing - Guided
12.00 - 13.00	Lunch - Symposium (lunchbox)	TBA
	Innovative study designs - Chair - Jiri Bartek
13.00 - 13.20	Register randomized trials - what can neuro-oncology learn from the BROKEN-SWEDEHEART?	Elmir Omerovic, Gothenburg/Sweden
13.20 - 13.40	Window-of-opprtunity studies	Michael Vogelbaum, Tampa/USA
13.40 - 14.00	Basket and umbrella trials	Benedikte Hasselbalch, Copenhagen/Denmark
	Basic research topic - Chair - Helena Carén
14.15 - 14.30	Spatial organization of diffuse gliomas	Aliisa Tiihonen, Finland
14.30 - 14.45	GBM organoids, how and why	Magnar Bjørås, Trondheim/Norway
14.45 - 15.00	3D chromatin organization of the glioblastoma genome	Silvia Remeseiro, Umeå/Sweden
15.00 - 15.15	Novel insight into glioblastoma heterogeneity	Bjarne W. Kristensen, Copenhagen/Denmark
15.15 - 15.22	Abstract
15.22 - 15.29	Abstract
15.30 - 16.00	Coffee/Exhibition
	Novel therapies - Chair - Asgeir Jakola
16.00 - 16.30	Immunotherapies including CAR-T in neuro-oncology	Magnus Essand, Uppsala/Sweden
16.30 - 17.00	Neurosurgical role in oncological therapy: towards truly multidisciplinary treatment?	Michael Vogelbaum, Tampa/USA

19.00 - 22.00	CONGRESS DINNER

April 27
	Abstract session and New concepts in IDH mutant gliomas - Chair - Asgeir Jakola
09.00 - 09.10	Best abstract clincal
09.10 - 09.20	Best abstract clincal
09.20 - 09.30	Best abstract basic
09.30 - 09.40	Best abstract basic
09.40 - 10.10	Vorasidenib in IDH mutated gliomas	Roberta Ruda, Turin/Italy

10.10 - 10.30	Coffee/Exhibition
	Glioma origin and growth - Chair - Magnus Olivecrona
10.30 - 10.37	Best abstract basic
10.37 - 10.45	Best abstract basic
10.45 - 11.00	Are gliomas inheritable?	Adam Rosenbaum, Umeå/Sweden
11.00 - 11.15	Glioma invasion: what can we learn from current models?	Sven Nelander, Uppsala/Sweden
	Trial updates with focus on the Nordics - Chair - Roger Henriksson
11.20 - 11.27	Abstract
11.28 - 11.35	Abstract
11.35 - 11.50	Temozolamide and Lomustine in MGMT methylated glioblastoma	Annika Malmström, Linköping/Sweden
11.50 - 12.45	Lunch - Mini symposium	TBA
	Trial updates with focus on the Nordic countries - Chair - Roger Henriksson
12.45 - 13.00	Optimized PCNSL treatment with BBB disruption	Hanne Kuitunen, Oulo/Finland
13.00 - 13.15	Scandinavian standard of care in surgical management of LGG	Margret Jensdottir, Stockholm/Sweden
13.15 - 13.30	Skull remodelling to improve TTF	Anders Korshøj, Aarhus/Denmark
13.30 - 13.45	Norwegian Brain Tumor Consortium: improved access to trials	Petter Brandal, Oslo/Norway
13.45 - 14.00	Tumor deliniation, novel fluorescent agents	Jane S. Rasmussen, Copenhagen/Denmark
14.00 - 14.10	ADJOURN	Asgeir Jakola, Gothenburg/Sweden

Skriv ut

SNOG SYMPOSIUM 2024 – Multidisciplinary Neuro-Oncology Meeting

Description